Loading…

Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition)

Background Hand, foot, and mouth disease (HFMD) is a common infectious disease in childhood caused by an enterovirus (EV), and which is principally seen in children under 5 years of age. To promote diagnostic awareness and effective treatments, to further standardize and strengthen the clinical mana...

Full description

Saved in:
Bibliographic Details
Published in:World journal of pediatrics : WJP 2018-10, Vol.14 (5), p.437-447
Main Authors: Li, Xing-Wang, Ni, Xin, Qian, Su-Yun, Wang, Quan, Jiang, Rong-Meng, Xu, Wen-Bo, Zhang, Yu-Cai, Yu, Guang-Jun, Chen, Qiang, Shang, Yun-Xiao, Zhao, Cheng-Song, Yu, Hui, Zhang, Ting, Liu, Gang, Deng, Hui-Ling, Gao, Jie, Ran, Xian-Gui, Yang, Qiao-Zhi, Xu, Bian-Li, Huang, Xue-Yong, Wu, Xing-Dong, Bao, Yi-Xiao, Chen, Yi-Ping, Chen, Zhi-Hai, Liu, Qing-Quan, Lu, Guo-Ping, Liu, Chun-Feng, Wang, Rong-Bing, Zhang, Guo-Liang, Gu, Fang, Xu, Hong-Mei, Li, Ying, Yang, Tao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Hand, foot, and mouth disease (HFMD) is a common infectious disease in childhood caused by an enterovirus (EV), and which is principally seen in children under 5 years of age. To promote diagnostic awareness and effective treatments, to further standardize and strengthen the clinical management and to reduce the mortality of HFMD, the guidelines for diagnosis and treatment have been developed. Methods National Health Commission of China assembled an expert committee for a revision of the guidelines. The committee included 33 members who are specialized in diagnosis and treatment of HFMD. Results Early recognition of severe cases is utmost important in diagnosis and treatment of patients with HFMD. The key to diagnosis and treatment of severe cases lies in the timely and accurate recognition of stages 2 and 3 of HFMD, in order to stop progression to stage 4. Clinicians should particularly pay attention to those EV-A71 cases in children aged less than 3 years, and those with disease duration less than 3 days. The following indicators should alert the clinician of possible deterioration and impending critical disease: (1) persistent hyperthermia; (2) involvement of nervous system; (3) worsening respiratory rate and rhythm; (4) circulatory dysfunction; (5) elevated peripheral WBC count; (6) elevated blood glucose and (7) elevated blood lactic acid. For treatment, most mild cases can be treated as outpatients. Patients should be isolated to avoid cross-infection. Intense treatment modalities should be given for those severe cases. Conclusion The guidelines can provide systematic guidance on the diagnosis and management of HFMD.
ISSN:1708-8569
1867-0687
DOI:10.1007/s12519-018-0189-8